More Skin in the Game: Screening for Skin Cancer in IBD Patients

More Skin in the Game: Screening for Skin Cancer in IBD Patients Digestive Diseases and Sciences (2018) 63:2497–2499 https://doi.org/10.1007/s10620-018-5136-y EDITORIAL 1 1 Seema A. Patil  · Raymond K. Cross Published online: 4 June 2018 © Springer Science+Business Media, LLC, part of Springer Nature 2018 Optimal care of patients with inflammatory bowel disease Melanoma rates are increasing annually, with the Amer- (IBD), though usually discussed in terms of diagnostic test- ican Cancer Society estimating there will be 91,270 new ing, procedures, and therapeutic interventions, also requires cases and 9,320 deaths attributed to melanoma in 2018. close attention to preventive care and health maintenance. NMSC is the most common of all types of cancer, with Healthcare maintenance is essential since the medications an estimated 3.3 million Americans diagnosed each year. used for treatment of IBD are accompanied by often prevent- Eighty and twenty percent are basal cell and squamous cell able adverse effects, and also because many IBD patients cancers, respectively. Nevertheless, death from these can- consider their gastroenterologist to be their primary care cers is not common. About 2000 people die from NMSC provider. in the USA each year [4]. No randomized controlled stud- Among all types of cancers, skin cancers appear to among ies have been conducted to establish the efficacy of skin the most increased http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Digestive Diseases and Sciences Springer Journals

More Skin in the Game: Screening for Skin Cancer in IBD Patients

Loading next page...
 
/lp/springer_journal/more-skin-in-the-game-screening-for-skin-cancer-in-ibd-patients-M4jwfV11OE
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Medicine & Public Health; Gastroenterology; Hepatology; Oncology; Transplant Surgery; Biochemistry, general
ISSN
0163-2116
eISSN
1573-2568
D.O.I.
10.1007/s10620-018-5136-y
Publisher site
See Article on Publisher Site

Abstract

Digestive Diseases and Sciences (2018) 63:2497–2499 https://doi.org/10.1007/s10620-018-5136-y EDITORIAL 1 1 Seema A. Patil  · Raymond K. Cross Published online: 4 June 2018 © Springer Science+Business Media, LLC, part of Springer Nature 2018 Optimal care of patients with inflammatory bowel disease Melanoma rates are increasing annually, with the Amer- (IBD), though usually discussed in terms of diagnostic test- ican Cancer Society estimating there will be 91,270 new ing, procedures, and therapeutic interventions, also requires cases and 9,320 deaths attributed to melanoma in 2018. close attention to preventive care and health maintenance. NMSC is the most common of all types of cancer, with Healthcare maintenance is essential since the medications an estimated 3.3 million Americans diagnosed each year. used for treatment of IBD are accompanied by often prevent- Eighty and twenty percent are basal cell and squamous cell able adverse effects, and also because many IBD patients cancers, respectively. Nevertheless, death from these can- consider their gastroenterologist to be their primary care cers is not common. About 2000 people die from NMSC provider. in the USA each year [4]. No randomized controlled stud- Among all types of cancers, skin cancers appear to among ies have been conducted to establish the efficacy of skin the most increased

Journal

Digestive Diseases and SciencesSpringer Journals

Published: Jun 4, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off